FINANCIALS

JANX Janux Therapeutics Inc 1817713

Income Statement
Revenue	janx-20241231	10,588,000
Net Income	janx-20241231	-68,994,000
Profit Margin		-651.62%

Balance Sheet
Current Assets	1,033,666,000
Assets	1,061,516,000
Current Liabilities	17,459,000
Liabilities	38,735,000
Equity	1,022,781,000
Shares Out	52,164,000

Cash Flow Statement
Operating Cash Flow	-43,814,000
Investing Cash Flow	-258,021,000

Market Analysis
Market Cap	2,562,059,505
Price	31.27
BVPS	19.61
PB	1.58
EPS	-0.92
PS	60.49
FCF	-301,835,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view JANX documents filed with the SEC.

JANX Filings Clear

View A List of Tickers